Journal of Endocrinological Investigation

, Volume 30, Issue 4, pp 268–273 | Cite as

Acquired prolactin deficiency in patients with disorders of the hypothalamic-pituitary axis

Original Articles


Acquired PRL deficiency occurs when the anterior pituitary is functionally destroyed, and it usually accompanies other pituitary hormone deficiencies. We retrospectively investigated in an outpatient endocrine clinic of a major tertiary medical center the prevalence and clinical characteristics of acquired PRL deficiency in patients with diseases of the hypothalamic-pituitary axis. The study included 100 consecutive patients, 61 men and 39 women, aged 4–79 yr at diagnosis. Patients were divided by PRL level to normal (>5 ng/ml), mild (3–5 ng/ml), and severe deficiency (<3 ng/ml). Twenty-seven patients (27%) had PRL deficiency, 13 mild deficiency and 14 severe deficiency. Patients with severe PRL deficiency tend to be younger at diagnosis (mean age, 37.5±21.8 yr) than patients with normal PRL (46±18.5 yr; ns). Underlying diseases including pituitary apoplexy, non-functioning pituitary adenoma, craniopharyngioma, and idiopathic hypogonadotropic hypogonadism were associated with PRL deficiency. The incidence of severe PRL deficiency rose with an increase in the number of other pituitary hormone deficits (ACTH, TSH, gonadotropin, vasopressin), from 0 in patients with no other deficits to 38% in patients with 4 deficits (p=0.006). Patients with severe deficiency had a mean of 3 hormone deficits compared to 1.8 in the other groups (p=0.006). PRL deficiency was significantly associated with TSH, ACTH and GH deficiency. Conclusions: PRL deficiency is common in patients with hypothalamic-pituitary disorders, especially pituitary apoplexy and craniopharyngioma. Acquired severe PRL deficiency can be considered a marker for extensive pituitary damage and a more severe degree of hypopituitarism.


Apoplexy craniopharyngioma hypopituitarism pituitary prolactin 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 1998, 19: 225–68.PubMedCrossRefGoogle Scholar
  2. 2.
    Tatsumi K, Miyai K, Notomi T, et al. Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nat Genet 1992, 1: 56–8.PubMedCrossRefGoogle Scholar
  3. 3.
    Radovick S, Nations M, Du Y, Berg LA, Weintraub BD, Wondisford FE. A mutation in the POU-homeodomain if Pit-1 responsible for combined pituitary hormone deficiency. Science 1992, 257: 1115–8.PubMedCrossRefGoogle Scholar
  4. 4.
    Pfaffle RW, DiMattia GE, Parks JS, et al. Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 1992, 257: 1118–21.PubMedCrossRefGoogle Scholar
  5. 5.
    Pellegrini-Bouiller I, Belicar P, Barlier A, et al. A new mutation of the gene encoding the transcription factor Pit-1 is responsible for combined pituitary hormone deficiency. J Clin Endocrinol Metab 1996, 81: 2790–6.PubMedGoogle Scholar
  6. 6.
    Pfaffle RW, Blankenstein O, Wuller S, Kentrup H. Combined pituitary hormone deficiency: role of Pit-1 and Prop-1. Acta Paediatr Suppl 1999, 88: 33–41.PubMedCrossRefGoogle Scholar
  7. 7.
    Turton JP, Reynaud R, Mehta A, et al. Novel mutations within the POU1F1 gene associated with variable combined pituitary hormone deficiency. J Clin Endocrinol Metab 2005, 90: 4762–70.PubMedCrossRefGoogle Scholar
  8. 8.
    Asteria C, Oliveira JH, Abucham J, Beck-Peccoz P. Central hypocortisolism as part of combined pituitary hormone deficiency due to mutations of PROP-1 gene. Eur J Endocrinol 2000, 143: 347–52.PubMedCrossRefGoogle Scholar
  9. 9.
    Rodriguez R, Andersen B. Cellular determination in the anterior pituitary gland: PIT-1 and PROP-1 mutations as causes of human combined pituitary hormone deficiency. Minerva Endocrinol 2003, 28: 123–33.PubMedGoogle Scholar
  10. 10.
    Vance ML. Hypopituitarism. N Engl J Med 1994, 330: 1651–62.PubMedCrossRefGoogle Scholar
  11. 11.
    Mukherjee A, Murray RD, Columb B, Gleeson HK, Shalet SM. Acquired prolactin deficiency indicates severe hypopituitarism in patients with disease of the hypothalamic-pituitary axis. Clinical Endocrinol (Oxf) 2003, 59: 743–8.CrossRefGoogle Scholar
  12. 12.
    Kauppila A, Chatelain P, Kirkinen P, Kivinen S, Ruokonen A. Isolated prolactin deficiency in a woman with puerperal alactogenesis. J Clin Endocrinol Metab 1987, 64: 309–12.PubMedCrossRefGoogle Scholar
  13. 13.
    Falk RJ. Isolated prolactin deficiency: a case report. Fertil Steril 1992, 58: 1060–2.PubMedGoogle Scholar
  14. 14.
    Zargar AH, Masoodi SR, Laway BA, Shah NA, Salahudin M. Familial puerperal alactogenesis: possibility of a genetically transmitted isolated prolactin deficiency. Br J Obstet Gynaecol 1997, 104: 629–31.PubMedCrossRefGoogle Scholar
  15. 15.
    Douchi T, Nakae M, Yamamoto S, Iwamoto I, Oki T, Nagata Y. A woman with isolated prolactin deficiency. Acta Obstet Gynecol Scand 2001, 80: 368–70.PubMedGoogle Scholar
  16. 16.
    Ozbey N, Inanc S, Aral F, et al. Clinical and laboratory evaluation of 40 patients with Sheehan’s syndrome. Isr J Med Sci 1994, 30: 826–9.PubMedGoogle Scholar
  17. 17.
    Sert M, Tetiker T, Kirim S, Kocak M. Clinical report of 28 patients with Sheehan’s syndrome. Endocr J 2003, 50: 297–301.PubMedCrossRefGoogle Scholar
  18. 18.
    Ben-Jonathan N, Mershon JL, Allen DL, Steinmetz RW. Extrapituitary prolactin: distribution, regulation, functions, and clinical aspects. Endocr Rev 1996, 17: 639–69.PubMedGoogle Scholar
  19. 19.
    Lahat N, Miller A, Shtiller R, Touby E. Differential effects of prolactin upon activation and differentiation of human B lymphocytes. J Neuroimmunol 1993, 47: 35–40.PubMedCrossRefGoogle Scholar
  20. 20.
    Walker SE, Allen SH, Hoffman RW, McMurray RW. Prolactin: a stimulator of disease activity in systemic lupus erythematosus. Lupus 1995, 4: 3–9.PubMedCrossRefGoogle Scholar
  21. 21.
    Sassolas G, Borson-Chazot F, Jaquet P, et al. GH deficiency in adults: an epidemiological approach. Eur J Endocrinol 1999, 141: 595–600.PubMedCrossRefGoogle Scholar
  22. 22.
    Mukherjee A, Murray RD, Teasdale GM, Shalet SM. Acquired prolactin deficiency (APD) after treatment for Cushing’s disease is a reliable marker of irreversible severe GHD but does not reflect disease status. Clin Endocrinol (Oxf) 2004, 60: 476–83.CrossRefGoogle Scholar
  23. 23.
    Mukherjee A, Ryder WDJ, Jostel A, Shalet SM. Prolactin deficiency is independently associated with reduced insulin-like growth factor I status in severely growth hormone-deficient adults. J Clin Endocrinol Metab 2006, 91: 2520–5.PubMedCrossRefGoogle Scholar
  24. 24.
    Zayour DH, Selman WR, Arafah BM. Extreme elevation of intrasellar pressure in patients with pituitary tumor apoplexy: Relation to pituitary function. J Clin Endocrinol Metab 2004, 89: 5649–54.PubMedCrossRefGoogle Scholar
  25. 25.
    Arafah BM, Prunty D, Ybarra J, Hlavin ML, Selman WR. The dominant role of increased intrasellar pressure in the pathogenesis of hypopituitarism, hyperprolactinemia, and headaches in patients with pituitary adenomas. J Clin Endocrinol Metab 2000, 85: 1789–93.PubMedGoogle Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 2007

Authors and Affiliations

  1. 1.Unit of Endocrinology and DiabetesHillel Yaffe Medical CenterHadera
  2. 2.Chaim Sheba Medical CenterInstitute of Thrombosis and HemostasisTel Hashomer
  3. 3.Rabin Medical CenterInstitute of EndocrinologyPetah TiqwaIsrael
  4. 4.Sackler Faculty of MedicineTel Aviv UniversityTel AvivIsrael

Personalised recommendations